Exelixis
EXEL
#1562
Rank
โ‚ฌ12.21 B
Marketcap
49,29ย โ‚ฌ
Share price
-0.21%
Change (1 day)
50.00%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company